Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry

被引：0

作者：

de la Torre, Esther Prados ^{[1
]}

Serrano, Josefina ^{[1
]}

Martinez-Cuadron, David ^{[2
,3
]}

Torres, Laura ^{[2
,3
]}

Sargas, Claudia ^{[4
]}

Ayala, Rosa ^{[5
]}

Bilbao-Sieyro, Cristina ^{[6
]}

Chillon, Maria Carmen ^{[7
]}

Larrayoz, Maria Jose ^{[8
]}

Soria, Elena ^{[9
]}

Aparicio-Perez, Clara ^{[1
]}

Bergua, Juan M. ^{[10
]}

Bernal, Teresa ^{[11
]}

Gil, Cristina ^{[12
]}

Tormo, Mar ^{[13
]}

Algarra, Lorenzo ^{[14
]}

Alonso-Dominguez, Juan M. ^{[15
]}

Rodriguez-Arboli, Eduardo ^{[9
]}

Martinez-Sanchez, Pilar ^{[5
]}

Oliva, Ana ^{[16
]}

Colorado-Araujo, Ana M. ^{[17
]}

Rodriguez-Medina, Carlos ^{[6
]}

Vives, Susana ^{[18
]}

Hermosin, Lourdes ^{[19
]}

Martinez-Lopez, Joaquin ^{[5
]}

Garcia-Sanz, Ramon ^{[7
]}

Perez-Simon, Jose A. ^{[9
]}

Calasanz, Maria Jose ^{[8
]}

Gomez-Casares, Maria Teresa ^{[6
]}

Barragan, Eva ^{[3
,20
]}

Sanchez-Garcia, J. Joaquin ^{[1
]}

Montesinos, Pau ^{[3
]}

ETHEMA group, P. E. T. H. E. M. A. group

机构：

[1] Univ Cordoba UCO, UGC Hematol Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIB, Cordoba, Argentina

[2] Hosp Univ & Politecn La Fe, Serv Hematol, Grp Acreditado Invest Hematol, Inst Invest Sanitaria Fe IIS La Fe, Valencia, Spain

[3] Inst Invest Sanitaria Fe IIS La Fe, Ctr Invest Biomed Red Canc CIBERONC, Valencia, Spain

[4] Inst Invest Sanitaria Fe IIS Fe, Grp Acreditado Invest Hematol, Valencia, Spain

[5] Univ Complutense, Hosp Univ 12 Octubre, Haematol & Haemotherapy Dept, Spanish Natl Canc Res Ctr CNIO, Madrid, Spain

[6] Univ Palmas Gran Canaria, Hosp Univ Gran Canaria Dr Negrin, Unit Endocrinol Nutr & Dietotherapy, Hosp Univ Gran Canaria Dr, Las Palmas Gran Canaria, Spain

[7] Hosp Univ Salamanca HUS IBSAL, Ctr Invest Canc IBMCC USAL CSIC, Serv Hematol, CIBERONC, Salamanca, Spain

[8] Univ Navarra, Navarra Inst Hlth Res, Hematol Dis Lab, CIMA LAB Diagnost, Pamplona, Spain

[9] Univ Seville, Hosp Univ Virgen Rocio, Inst Biomed IBIS CSIC, Seville, Spain

[10] Hosp Univ San Pedro Alcantara, Caceres, Spain

[11] Hosp Univ Cent Asturias, Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain

[12] Hosp Gen Univ Alicante, Alicante, Spain

[13] Univ Valencia, Hosp Clin Univ, Inst Invest INCL, Valencia, Spain

[14] Hosp Gen Univ, Albacete, Spain

[15] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

[16] Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain

[17] Hosp Univ Marques Valdecilla, Santander, Spain

[18] Hosp Univ Germans Trias i Pujol ICO Badalona, Badalona, Spain

[19] Hosp Gen Jerez Frontera, Jerez de la Frontera, Spain

[20] Hosp Univ & Politecn La Fe, Serv Anal Clin, Grp Acreditado Invest Hematol, Inst Invest Sanitaria Fe IIS La Fe, Valencia, Spain

来源：

HAEMATOLOGICA | 2024年 / 109卷 / 08期

关键词：

HEALTH-ORGANIZATION CLASSIFICATION; MUTATIONS; AML;

D O I：

10.3324/haematol.2023.284601

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2682 / 2687

页数：6

共 50 条

[21] Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience
Labrador, Jorge
Saiz-Rodriguez, Miriam
de Miguel, Dunia
de Laiglesia, Almudena
Rodriguez-Medina, Carlos
Vidriales, Maria Belen
Perez-Encinas, Manuel
Jose Sanchez-Sanchez, Maria
Cuello, Rebeca
Roldan-Perez, Alicia
Vives, Susana
Benzo-Callejo, Gonzalo
Colorado, Mercedes
Garcia-Fortes, Maria
Jose Sayas, Maria
Olivier, Carmen
Recio, Isabel
Conde-Royo, Diego
Bienert-Garcia, Alvaro
Vahi, Maria
Munoz-Garcia, Carmen
Seri-Merino, Cristina
Tormo, Mar
Vall-llovera, Ferran
Foncillas, Maria-Angeles
Martinez-Cuadron, David
Sanz, Miguel Angel
Montesinos, Pau
CANCERS, 2022, 14 (07)
[22] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia
Ahn, Jae-Sook
Kim, Mihee
Ahn, Seo-Yeon
Kim, Mi Yeon
Song, Ik Chan
Park, Yong
Cheong, June-Won
Yhim, Ho-Young
Do, Young Rok
Lee, Yoo Jin
Park, Seong Kyu
Bae, Sung Hwa
Shin, Ho-Jin
Lee, Hyewon
Han, Jae Joon
Kim, Min Kyoung
Lee, Ho Sup
Jung, Chul Won
Jang, Jun Ho
Moon, Joon Ho
Sohn, Sang Kyun
Won, Jong-Ho
Kim, Sung-Hyun
Kim, Dennis D. H.
Kim, Heeje
Kim, Hyeoung Joon
BLOOD, 2023, 142
[23] Aberrant Expression of MIR9 Represents a Distinct Entity with Poor Prognosis in Acute Myeloid Leukemia
Maki, Kazuhiro
Yamagata, Tetsuya
Sugita, Fusako
Nakamura, Yuka
Sasaki, Ko
Mitani, Kinuko
BLOOD, 2011, 118 (21) : 1086 - 1086
[24] Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study
Lloret-Madrid, Pilar
Boluda, Blanca
Martinez-Lopez, Joaquin
Bergua, Juan
Rodriguez Arboli, Eduardo
Labrador, Jorge
Sossa, Claudia
Gil, Cristina
Algarra, Lorenzo
Lavilla-Rubira, Esperanza
Serrano, Josefina
de Rueda, Beatriz
Ibanez, Francisco
Gonzalez, Bernardo J. Gonzalez
Amigo, Maria Luz
Garcia Belmonte, Daniel
Rodriguez-Medina, Carlos
Gomez-Roncero, Maria I.
Colorado, Mercedes
Lopez Lorenzo, Jose L.
Tormo, Mar
Fernandez, Olga Arce
Cano-Ferri, Isabel
Solana-Altabella, Antonio
Foncillas, Maria-Angeles
Alfonso Pierola, Ana
Vives, Susana
Nunez, Marta Valero
Lopez-Vidal, Hernan
Perez-Santaolalla, Esther
Hermosin Ramos, Lourdes
Garcia Boyero, Raimundo
Gonzalez, Laura Llorente
Roldan, Alicia
Calderon, Soledad Casado
Infante, Joana Brioso
Olave, Teresa
Garcia-Suarez, Julio
de Laiglesia, Almudena
Rodriguez-Veiga, Rebeca
Trigo, Fernanda
Martinez-Cuadron, David
Montesinos, Pau
CANCER, 2025, 131 (01)
[25] Prognostic Analysis of GATA2 Mutations in CEBPA-Mutated Acute Myeloid Leukemia
Marceau-Renaut, Alice
Cheok, Meyling
Duployez, Nicolas
Nibourel, Olivier
Helevaut, Nathalie
Rodriguez, Celine
Celli-Lebras, Karine
Berthon, Celine
Leverger, Guy
Boissel, Nicolas
Terre, Christine
Thomas, Xavier
Castaigne, Sylvie
Dombret, Herve
Preudhomme, Claude
Renneville, Aline
BLOOD, 2014, 124 (21)
[26] Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
Ruecker, Frank G.
Corbacioglu, Andrea
Krzykalla, Julia
Cocciardi, Sibylle
Lengerke, Claudia
Germing, Ulrich
Wulf, Gerald
Samra, Maisun A.
Teichmann, Lino L.
Luebbert, Michael
Kuehn, Michael W. M.
Bentz, Martin
Westermann, Joerg
Bullinger, Lars
Gaidzik, Verena I.
Meid, Annika
Aicher, Sophia
Stegelmann, Frank
Weber, Daniela
Schrade, Anika
Thol, Felicitas
Heuser, Michael
Ganser, Arnold
Benner, Axel
Doehner, Hartmut
Doehner, Konstanze
HEMASPHERE, 2024, 8 (07):
[27] Clinical Relevance of Concomitant Gene Mutations in CEBPA Double-Mutated Acute Myeloid Leukemia
Grossmann, Vera
Schnittger, Susanne
Nadarajah, Niroshan
Weissmann, Sandra
Fasan, Annette
Eder, Christiane
Stopp, Elisa
Kern, Wolfgang
Haferlach, Torsten
Kohlmann, Alexander
Haferlach, Claudia
BLOOD, 2012, 120 (21)
[28] Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome
Dufour, Annika
Schneider, Friederike
Metzeler, Klaus H.
Hoster, Eva
Schneider, Stephanie
Zellmeier, Evelyn
Benthaus, Tobias
Sauerland, Maria-Cristina
Berdel, Wolfgang E.
Buechner, Thomas
Woermann, Bernhard
Braess, Jan
Hiddemann, Wolfgang
Bohlander, Stefan K.
Spiekermann, Karsten
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 570 - 577
[29] ACUTE MYELOID LEUKEMIA WITH BIALLELIC CEBPA GENE MUTATIONS AND NORMAL KARYOTYPE REPRESENTS A DISTINCT GENETIC ENTITY ASSOCIATED WITH A FAVORABLE CLINICAL OUTCOME
Dufour, A.
Schneider, F.
Metzeler, K. H.
Zellmeier, E.
Benthaus, T.
Sauerland, M-C
Buechner, T.
Braess, J.
Hiddemann, W.
Bohlander, S.
Spiekermann, K.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 19 - 19
[30] TP53/NPM1-mutated acute myeloid leukemia as a molecularly distinct disease entity.
Scarpa, Frank J.
Paul, Madhuri
Daringer, Rachel
Wolfson, Wendy A.
Diaz, Fernando Lopez
Agersborg, Sally
Funari, Vincent Anthony
Weiss, Lawrence Martin
Blocker, Forrest
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →